These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 16542875)

  • 1. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
    Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
    J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant BCG vaccine candidates.
    Hernàndez-Pando R; Castañòn M; Espitia C; Lopez-Vidal Y
    Curr Mol Med; 2007 Jun; 7(4):365-72. PubMed ID: 17584076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis: vaccines in the pipeline.
    Ly LH; McMurray DN
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategies for the development of new tuberculosis vaccines].
    Fattorini L
    Minerva Med; 2007 Apr; 98(2):109-19. PubMed ID: 17519853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis: from genome to vaccine.
    de Jonge MI; Brosch R; Brodin P; Demangel C; Cole ST
    Expert Rev Vaccines; 2005 Aug; 4(4):541-51. PubMed ID: 16117711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis vaccines: past, present and future.
    Martin C
    Curr Opin Pulm Med; 2006 May; 12(3):186-91. PubMed ID: 16582673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Search for new tuberculosis vaccines].
    Gicquel B
    Bull Acad Natl Med; 1999; 183(7):53-61; discussion 61-2. PubMed ID: 10622122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB; Kalra M; Verma I; Khuller GK
    Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development.
    Kamath AT; Fruth U; Brennan MJ; Dobbelaer R; Hubrechts P; Ho MM; Mayner RE; Thole J; Walker KB; Liu M; Lambert PH; ;
    Vaccine; 2005 May; 23(29):3753-61. PubMed ID: 15893612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J; Vipond R; Allen-Vercoe E; Clark SO; Hatch GJ; Gooch KE; Bacon J; Hampshire T; Shuttleworth H; Minton NP; Blake K; Williams A; Marsh PD
    Vaccine; 2006 Sep; 24(37-39):6340-50. PubMed ID: 16781800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.
    Sambandamurthy VK; Wang X; Chen B; Russell RG; Derrick S; Collins FM; Morris SL; Jacobs WR
    Nat Med; 2002 Oct; 8(10):1171-4. PubMed ID: 12219086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in improved tuberculosis vaccines.
    McMurray DN
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S58-62. PubMed ID: 11129910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The second Geneva Consensus: Recommendations for novel live TB vaccines.
    Walker KB; Brennan MJ; Ho MM; Eskola J; Thiry G; Sadoff J; Dobbelaer R; Grode L; Liu MA; Fruth U; Lambert PH
    Vaccine; 2010 Mar; 28(11):2259-70. PubMed ID: 20074686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprophylaxis of tuberculosis: an update of emerging trends.
    Singhal N; Bisht D; Joshi B
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):97-106. PubMed ID: 20140756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis.
    Aguilar LD; Infante E; Bianco MV; Cataldi A; Bigi F; Pando RH
    Vaccine; 2006 Mar; 24(13):2333-42. PubMed ID: 16388878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection.
    Collins DM; de Lisle GW; Aldwell FE; Buddle BM
    Vaccine; 2007 Jun; 25(24):4659-64. PubMed ID: 17498852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.